Skip to main content

What the FDA labels say about taking them together

Granisetron and phenobarbital

Granisetron's FDA label of August 31, 2017 names phenobarbital in its drug interactions section; the phenobarbital labels PlainMeds reads (2) do not name granisetron. The granisetron label: “In a human pharmacokinetic study, hepatic enzyme induction with phenobarbital resulted in a 25% increase in total plasma clearance of intravenous granisetron hydrochloride.”

Check it at the source: the granisetron FDA label on DailyMed (effective August 31, 2017, Mylan Institutional LLC); the phenobarbital FDA label on DailyMed (effective August 27, 2026).

What does the granisetron label say about phenobarbital?

Granisetron label, drug interactions

In a human pharmacokinetic study, hepatic enzyme induction with phenobarbital resulted in a 25% increase in total plasma clearance of intravenous granisetron hydrochloride.

Source: FDA drug label (Granisetron Hydrochloride), Mylan Institutional LLC, effective August 31, 2017 (SPL set 8d88adba-7f5e-4e97-84b3-6ca8ec98c023), via openFDA; the full label on DailyMed

What does the phenobarbital label say about granisetron?

Phenobarbital's label (effective August 27, 2026) and its 1 other brand-application label do not name granisetron in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Phenobarbital), Chartwell RX, LLC, effective August 27, 2026 (SPL set 74428144-fb24-40a5-a670-3b876e2d116c), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

8Granisetron generic labelers
0Phenobarbital generic labelers
GranisetronPhenobarbital
Labeled forNausea and vomitingSeizures and epilepsy
Boxed warningNoNo
Pharmacy cost (NADAC)$1.31 per tablet 1 mg tablet$0.213 per tablet 100 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?